Agenda

Day 1 - Tuesday, June 16, 2020

8:30
Registration and Networking
9:00
Opening Remarks from the Conference Chair
9:10

Year in Review

Analysing Key Legal Developments and Determining if SPCs are Still Fit for Their Purpose
10:30
Networking and Refreshments
11:00
Handling SPCs Based on Secondary Medical Use Applications
12:15
Lunch and Networking
1:15
“Protection by a Basic Patent in Force”: Pending Referrals on Art. 3(a) Requirements
2:30
Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents
3:30
Networking and Refreshments
4:00
National Patent Offices Speak on Overcoming Disparities of Protection in Europe
5:15
Chair’s Summary: Key Takeaways From Day 1
5:30
Conference Adjourns

Day 2 - Wednesday, June 17, 2020

9:00
Opening Remarks from the Conference Chair
9:15
Keynote Presentation
9:45
SPC Waiver (EU) 2019/933: Assessing the Impact of the Manufacturing Waiver One Year After Inception
10:45
Networking and Refreshments
11:15
Evaluating SPC eligibility in Non-Traditional and Novel Scenarios
12:30
Lunch and Networking
1:30
Seeking SPC Terms based on Third Party Marketing Authorisation (MA)
2:30
Maximising Paediatric Exclusivity: Study of the Recent Swiss Experience
3:00
Networking and Refreshments
3:30
Securing and Extending Data Exclusivity While Staying Compliant with the Latest Transparency Rules and Regulations
4:15
Chair’s Closing Remarks
4:30
Conference Ends

Day 1 - Tuesday, June 16, 2020

8:30
Registration and Networking
9:00
Opening Remarks from the Conference Chair
9:10

Year in Review

Analysing Key Legal Developments and Determining if SPCs are Still Fit for Their Purpose
10:30
Networking and Refreshments
11:00
Handling SPCs Based on Secondary Medical Use Applications
12:15
Lunch and Networking
1:15
“Protection by a Basic Patent in Force”: Pending Referrals on Art. 3(a) Requirements
2:30
Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents
3:30
Networking and Refreshments
4:00
National Patent Offices Speak on Overcoming Disparities of Protection in Europe
5:15
Chair’s Summary: Key Takeaways From Day 1
5:30
Conference Adjourns

Day 2 - Wednesday, June 17, 2020

9:00
Opening Remarks from the Conference Chair
9:15
Keynote Presentation
9:45
SPC Waiver (EU) 2019/933: Assessing the Impact of the Manufacturing Waiver One Year After Inception
10:45
Networking and Refreshments
11:15
Evaluating SPC eligibility in Non-Traditional and Novel Scenarios
12:30
Lunch and Networking
1:30
Seeking SPC Terms based on Third Party Marketing Authorisation (MA)
2:30
Maximising Paediatric Exclusivity: Study of the Recent Swiss Experience
3:00
Networking and Refreshments
3:30
Securing and Extending Data Exclusivity While Staying Compliant with the Latest Transparency Rules and Regulations
4:15
Chair’s Closing Remarks
4:30
Conference Ends